PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Amitriptyline hydrochloride - Migraine (prevention)
PAD Profile : Amitriptyline hydrochloride - Migraine (prevention)
Keywords :
migraine prophylaxis, antimigraine, migraine prevention
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Botulinum toxin type A
- Flunarizine dihydrochloride
- Pizotifen malate
- Erenumab
- Galcanezumab
- Fremanezumab
- Propranolol hydrochloride
- Topiramate
- Gabapentin
- Pregabalin
- Rimegepant
- Candesartan cilexetil
- Clonidine hydrochloride
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 February 2026
Committee Recommendations
Date
Committee Name
Narrative
07 July 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System (ICS) Area Prescribing Committee has agreed a GREEN traffic light status for amitriptyline for migraine prophylaxis in line with NICE Clinical Knowledge Summaries (CKS). Information in CKS is available by following this link https://cks.nice.org.uk/topics/migraine/prescribing-information/drugs-for-the-prevention-of-migraine/
Associated BNF Codes
04. Central Nervous System
04.07.04. Antimigraine drugs